Related Experiment Video
Updated: May 11, 2026

Peptide-based Identification of Functional Motifs and their Binding Partners
Published on: July 1, 2013
Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying
Insights
Patients with acquired immunodeficiency syndrome (AIDS) show reduced erythrocyte complement receptor 1 (E-CR1) levels, linked to increased immune complexes and complement activation, suggesting a role in disease progression.
Area of Science:
- Immunology
- Virology
- Complement System Biology
Background:
- Erythrocyte complement receptor 1 (E-CR1) plays a role in immune complex clearance.
- Acquired immunodeficiency syndrome (AIDS) is associated with immune dysregulation.
Purpose of the Study:
- To investigate E-CR1 levels in individuals with or at risk for AIDS.
- To correlate E-CR1 levels with circulating immune complexes (CIC) and complement activation.
Main Methods:
- Quantification of E-CR1 on erythrocytes.
- Assay of CIC using Raji cells and C1q binding.
- Measurement of complement activation via C3bi/C3d-g levels.
Main Results:
- Significantly reduced E-CR1 levels in AIDS patients compared to healthy controls (P < 0.001).
- E-CR1 reduction correlated with increased CIC levels (Raji cell assay).
- Elevated C3 activation markers (C3bi/C3d-g) observed in AIDS patients (P < 0.01).
Conclusions:
- The acquired reduction in E-CR1 in AIDS patients is associated with impaired immune complex handling.
- Increased CIC and complement activation suggest a role in AIDS pathogenesis.
- E-CR1 dysfunction may contribute to the clinical manifestations of AIDS.
Abstract:
We studied levels of erythrocyte C3b receptors (E-CR1) and correlated them to the level of circulating immune complexes (CIC) and complement activation in patients with or at risk for acquired immunodeficiency syndrome (AIDS). A significant reduction was found in patients with AIDS (185 +/- 93 CR1/cell), AIDS-related complex, and generalized lymphadenopathy, whereas healthy male homosexuals or normal controls had 434 +/- 193 and 509 +/- 140 CR1/cell, respectively (P less than 0.001). Family studies indicate that this defect is acquired. Reduction in E-CR1 was associated with increased levels of CIC when assayed by binding to Raji cells, but not when tested by C1q binding. Complement activation was assessed by levels of C3bi/C3d-g in plasma, measured with a monoclonal antibody specific for a neoantigen in C3d. AIDS patients had increased C3 activation (2.68 +/- 1.67%) when compared with normal controls (0.9 +/- 0.22%) (P less than 0.01). The decreased E-CR1, the presence of CIC, and C3 activation suggest that complement activation by immune complexes may play a role in the clinical expression of the disease.
Related Concept Videos
Humoral Immune Responses
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Sexually Transmitted Infections
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cytomegalovirus Disease
Hypersensitivity Reactions: Immune-Complex Reactions

